104
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Antinuclear antibody prevalence in a general pediatric cohort from Mexico City: discordance between immunofluorescence and multiplex assays

, , , , , , & show all
Pages 1-8 | Published online: 20 Dec 2016

References

  • Agmon-LevinNDamoiseauxJKallenbergCInternational recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodiesAnn Rheum Dis2014731172324126457
  • KavanaughATomarRReveilleJSolomonDHHomburgerHAGuidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of PathologistsArch Pathol Lab Med20001241718110629135
  • ArbuckleMRMcClainMTRubertoneMVScofieldRHDennisGJJamesJAHarleyJBDevelopment of autoantibodies before the clinical onset of systemic lupus erythematosusN Engl J Med2003349161526153314561795
  • Rantapää-DahlqvistSde JongB a WBerglinEAntibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritisArthritis Rheum200348102741274914558078
  • NielenMMJvan SchaardenburgDReesinkHWSimultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritisAnn Rheum Dis200665453553716079166
  • BrinkMHanssonMMathssonLMultiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritisArthritis Rheum201365489991023310951
  • VergeCFGiananiRKawasakiEYuLPietropaoloMChaseHPEisenbarthGSNumber of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type I diabetesJ Autoimmun1996933793838816974
  • BizzaroNAutoantibodies as predictors of disease: the clinical and experimental evidenceAutoimmun Rev20076632533317537376
  • CooperGSUnraveling the etiology of systemic autoimmune diseases: peering into the preclinical phase of diseaseJ Rheumatol20093691853185519738204
  • NIAMSNIAMS preclinical disease phase of skin and rheumatic autoimmune diseases roundtable summary2010 Available from: http://www.niams.nih.gov/News_and_Events/Meetings_and_Events/Roundtables/2010/preclinical_autoimmunity_roundtable.aspAccessed October 15, 2014
  • DeaneKDNorrisJMHolersVMPreclinical rheumatoid arthritis: identification, evaluation, and future directions for investigationRheum Dis Clin North Am201036221324120510231
  • DeaneKDEl-GabalawyHPathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLENat Rev Rheumatol201410421222824514912
  • TanEMFeltkampTESmolenJSRange of antinuclear antibodies in “healthy” individualsArthritis Rheum1997409160116119324014
  • SatohMChanEKLHoLAPrevalence and sociodemographic correlates of antinuclear antibodies in the United StatesArthritis Rheum20126472319232722237992
  • SperottoFCuffaroGBrachiSSegusoMZulianFPrevalence of antinuclear antibodies in schoolchildren during puberty and possible relationship with musculoskeletal pain: a longitudinal studyJ Rheumatol20144171405140824737914
  • HilárioMOELenCARojaSCTerreriMTAlmeidaGAndradeLECFrequency of antinuclear antibodies in healthy children and adolescentsClin Pediatr (Phila)200443763764215378151
  • MeroniPLSchurPHANA screening: an old test with new recommendationsAnn Rheum Dis20106981420142220511607
  • ShanmugamVKSwitowskiDRSaddicNWangHSteenVDComparison of indirect immunofluorescence and multiplex antinuclear antibody screening in systemic sclerosisClin Rheumatol201130101363136821614475
  • BrunerBFGuthridgeJMLuRComparison of autoantibody specificities between traditional and bead-based assays in a large, diverse collection of patients with systemic lupus erythematosus and family membersArthritis Rheum201264113677368623112091
  • XuMRobertsBBBusbyBAEvaluation of multiplex antinuclear antibody assay in pediatric patientsLab Med20073811671675
  • González-CossíoTPetersonKESanínLHDecrease in birth weight in relation to maternal bone-lead burdenPediatrics199710058568629346987
  • Hernandez-AvilaMPetersonKEGonzalez-CossioTSaninLHAroASchnaasLHuHEffect of maternal bone lead on length and head circumference of newborns and 1-month-old infantsArch Environ Health200257548248812641193
  • EttingerASLamadrid-FigueroaHTéllez-RojoMMEffect of calcium supplementation on blood lead levels in pregnancy: a randomized placebo-controlled trialEnviron Health Perspect20091171263119165383
  • BraunJMHoffmanESchwartzJAssessing windows of susceptibility to lead-induced cognitive deficits in Mexican childrenNeurotoxicology20123351040104722579785
  • BradwellAHughesRHardenEAtlas of Hep-2 Patterns2nd edBirmingham, UKThe Binding Site2003
  • VieraAJGarrettJMUnderstanding interobserver agreement: the kappa statisticFam Med200537536036315883903
  • GhirardelloAVillaltaDMorozziGEvaluation of current methods for the measurement of serum anti double-stranded DNA antibodiesAnn N Y Acad Sci20071109140140617785328
  • SchmelingHMahlerMLevyDMAutoantibodies to dense fine speckles in pediatric diseases and controlsJ Rheumatol201542122419242626472409
  • SomersECMarderWCagnoliPPopulation-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance ProgramArthritis Rheumatol201466236937824504809
  • LimSSBayaklyARHelmickCGGordonCEasleyKADrenkardCThe incidence and prevalence of systemic lupus erythematosus, 2002–2004: the Georgia Lupus RegistryArthritis Rheumatol201466235736824504808
  • HouseyMDeGuirePLyon-CalloSIncidence and prevalence of systemic lupus erythematosus among Arab and Chaldean Americans in southeastern Michigan: the Michigan Lupus Epidemiology and Surveillance ProgramAm J Public Health20151055e74e7925790387
  • SomersECThomasSLSmeethLSchoonenWMHallAJIncidence of systemic lupus erythematosus in the United Kingdom, 1990–1999Arthritis Rheum200757461261817471530
  • Dall’EraMCSnipesKCisternasMGordonCHelmickCGPreliminary population-based incidence and prevalence estimates of systemic lupus erythematosus: the California Lupus Surveillance ProjectArthritis Res Ther201416Suppl 1A38
  • IzmirlyPWanISahlSPreliminary population-based incidence and prevalence estimates of systemic lupus erythematosus from the Manhattan Lupus Surveillance ProgramArthritis Rheumatol201567Suppl 10
  • CooperGSBynumMLSomersECRecent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseasesJ Autoimmun2009333–419720719819109
  • LiQ-ZKarpDRQuanJRisk factors for ANA positivity in healthy personsArthritis Res Ther2011132R3821366908
  • American college of rheumatologyPosition statement: methodology of testing for antinuclear antibodies2011 Available from: https://www.rheumatology.org/Practice/Clinical/Position/Position_Statements/Accessed February 4, 2015
  • SatohMTanakaSChanEKThe uses and misuses of multiplex autoantibody assays in systemic autoimmune rheumatic diseasesFront Immunol2015641425657648
  • ShapiraYPoratkatzB-SGilburdBGeographical differences in autoantibodies and anti-infectious agents antibodies among healthy adultsClin Rev Allergy Immunol201242215416321229335
  • JurencákRFritzlerMTyrrellPHirakiLBenselerSSilvermanEAutoantibodies in pediatric systemic lupus erythematosus: ethnic grouping, cluster analysis, and clinical correlationsJ Rheumatol200936241642119208567
  • AllenRCDewezPStuartLGatenbyPASturgessAAntinuclear antibodies using HEp-2 cells in normal children and in children with common infectionsJ Paediatr Child Health199127139422043388
  • SomersECGanserMAWarrenJSBasuNWangLZickSMParkSKMercury exposure and antinuclear antibodies among females of reproductive age in the United States: NHANESEnviron Health Perspect201512387929825665152